Research compounds Early human study Hormone research
Also discussed as: Growth hormone releasing peptide-2
What it is and how it works
GHRP-2 acts at the growth-hormone secretagogue receptor, a receptor also involved in ghrelin signaling. Research has explored hormone release and appetite responses. These are measurable biological effects, but neither is a complete assessment of health or performance.
Source for the mechanism context →A closer look at the cited evidence
Early human study
This label describes the selected source below. It is not a complete ranking of the literature, a safety score, or an approval status.
- Study or assessment
- Laferrere et al., 2005 — GHRP-2 and food intake
- Design
- Small experimental comparison of GHRP-2 and saline.
- Who or what was studied
- Seven lean, healthy men.
- What was observed
- Participants ate more during the GHRP-2 condition than during the saline condition.
- Limits of interpretation
- A short-term appetite experiment does not establish long-term body-composition benefits, safety, or an appropriate clinical use.
What the evidence means
The clinical question and study population matter more than a broad performance claim.
Approval and regulatory context
Not an FDA-approved performance medicine.
Safety and uncertainty
Serious events reported; causality remains uncertain.
What remains uncertain
An appetite or hormone effect can have different implications depending on the clinical question. The experiment cannot resolve longer-term outcomes, risks in other populations, or claims about a wellness protocol.
These summaries are introductory and are not a complete account of the literature, adverse effects, contraindications, or interactions. Absence of a listed risk does not mean absence of risk. Different compounds, formulations, and routes cannot be treated as interchangeable.
Common questions about GHRP-2
What is GHRP-2, and what did the selected human study measure?
GHRP-2 is a growth-hormone secretagogue. The selected short experiment in seven lean men measured food intake, not long-term muscle gain, fat loss, or overall health. Participants ate more during the GHRP-2 condition.
Do GHRP-2 hormone effects prove fitness benefits?
No. A hormone response or appetite change does not establish meaningful improvements in strength, body composition, or long-term health. The selected experiment cannot establish safety in other populations or validate oral-product claims.
What safety concerns does FDA identify?
FDA describes potential immune-reaction and peptide-characterization concerns and reports serious events, including infection, pancreatitis, and deaths among critically ill study subjects. Causality has not been established. These uncertainties are not a safe-use protocol.
Related educational reading
Sources behind this overview
Read the source in its full context. Source links support the overview; they do not imply endorsement of this library by the source organization.
